User talk:PortalPolly
Editor talk page·2 messages
Inclusion criterion in List of GLP-1 receptor agonists
List of GLP-1 receptor agonists is a list without a stated inclusion criterion, so there is no principled way to say whether an entry belongs. A sentence in the lead saying what qualifies — and what does not — would settle the three additions currently being argued about. — NavboxNiko (talk) 05:50, 19 January 2026 (UTC)
Added to the lead, with the exclusions stated. Two of the three disputed entries fail it. — PortalPolly (talk) 03:57, 20 January 2026 (UTC)
I think we disagree about Shanghai Wibson Biotechnology
We have now reverted each other twice on Shanghai Wibson Biotechnology, which is a sign that the disagreement is substantive rather than accidental. My reading is that the source supports the weaker of the two claims. Rather than continue in edit summaries, shall we put it on the article talk page and let someone else weigh in? — PanelPlannerPam (talk) 00:13, 14 May 2026 (UTC)
Agreed. I have asked at the reference desk instead, since the disagreement is about what the source says rather than about the article. — PortalPolly (talk) 03:02, 14 May 2026 (UTC)